132 related articles for article (PubMed ID: 12136606)
1. [Molecular biology of ion channels in the heart].
Matsuoka T; Kurachi Y
Nihon Rinsho; 2002 Jul; 60(7):1292-8. PubMed ID: 12136606
[TBL] [Abstract][Full Text] [Related]
2. [Molecular structure and expression of ion channels in the heart].
Isomoto S; Kurachi Y
Nihon Rinsho; 1996 Aug; 54(8):2056-65. PubMed ID: 8810777
[TBL] [Abstract][Full Text] [Related]
3. Ion channels: structure and function.
Lawrence JH; Tomaselli GF; Marban E
Heart Dis Stroke; 1993; 2(1):75-80. PubMed ID: 7511968
[TBL] [Abstract][Full Text] [Related]
4. [Ion channels in cardiac tissue. Validity and limits of cellular electrophysiology in the interpretation of clinical data].
Spinnler MT; Mangiardi L; Di Francesco D; Ferroni A
G Ital Cardiol; 1985 Jun; 15(6):631-42. PubMed ID: 2415420
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutations and arrhythmia: simulation from DNA to electrocardiogram.
Zhu ZI; Clancy CE
J Electrocardiol; 2007; 40(6 Suppl):S47-50. PubMed ID: 17993328
[TBL] [Abstract][Full Text] [Related]
6. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.
Varró A; Papp JG
Cardioscience; 1992 Sep; 3(3):131-44. PubMed ID: 1384746
[TBL] [Abstract][Full Text] [Related]
7. [Anchoring proteins and cardiac sudden death: how and why?].
Pourrier M; Nattel S
Med Sci (Paris); 2004 Apr; 20(4):437-41. PubMed ID: 15124116
[TBL] [Abstract][Full Text] [Related]
8. Cardiac ion channels.
Katz AM
N Engl J Med; 1993 Apr; 328(17):1244-51. PubMed ID: 7681934
[No Abstract] [Full Text] [Related]
9. Electrophysiologic changes in heart failure: focus on pacemaker channels.
Sartiani L; Stillitano F; Cerbai E; Mugelli A
Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
[TBL] [Abstract][Full Text] [Related]
10. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.
Harrell MD; Harbi S; Hoffman JF; Zavadil J; Coetzee WA
Physiol Genomics; 2007 Feb; 28(3):273-83. PubMed ID: 16985003
[TBL] [Abstract][Full Text] [Related]
11. Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias.
Dai DZ; Yu F
Acta Pharmacol Sin; 2005 Aug; 26(8):918-25. PubMed ID: 16038623
[TBL] [Abstract][Full Text] [Related]
12. Proarrhythmia with non-antiarrhythmics. A review.
Albrecht CA
Cardiology; 2004; 102(3):122-39. PubMed ID: 15359098
[TBL] [Abstract][Full Text] [Related]
13. [Molecular basis of arrhythmias in patients with genetically-based cardiomyopathies: when the cytoskeleton meets the ion channels].
Vatta M
G Ital Cardiol (Rome); 2010 Oct; 11(10):746-52. PubMed ID: 21246775
[TBL] [Abstract][Full Text] [Related]
14. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Grunnet M
Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
[TBL] [Abstract][Full Text] [Related]
15. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
Michael G; Xiao L; Qi XY; Dobrev D; Nattel S
Cardiovasc Res; 2009 Feb; 81(3):491-9. PubMed ID: 18826964
[TBL] [Abstract][Full Text] [Related]
16. Mouse models for studying pacemaker channel function and sinus node arrhythmia.
Ludwig A; Herrmann S; Hoesl E; Stieber J
Prog Biophys Mol Biol; 2008; 98(2-3):179-85. PubMed ID: 19351513
[TBL] [Abstract][Full Text] [Related]
17. [Mutations in the heart's pacemaker channels--a new cause of sick sinus node syndrome and long-QT syndrome].
Vitved T; Lianee HT; Støvring B; Sigurd BM; Christiansen M
Ugeskr Laeger; 2008 Mar; 170(11):929-33. PubMed ID: 18397618
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of action of neurotoxins acting on the inactivation of voltage-gated sodium channels].
Benoit E
C R Seances Soc Biol Fil; 1998; 192(3):409-36. PubMed ID: 9759381
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic considerations in diseases of cardiac ion channels.
Anantharam A; Markowitz SM; Abbott GW
J Pharmacol Exp Ther; 2003 Dec; 307(3):831-8. PubMed ID: 14561846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
